The phrase "achieved relapse" is not commonly used in written English and may be confusing without context.
It could be used in discussions about recovery from addiction or mental health, where someone has returned to a previous state after a period of improvement.
Example: "After several months of sobriety, he unfortunately achieved relapse and had to start his recovery journey again."
Alternatives: "experienced relapse" or "suffered relapse".
Alternatively, the genetic testing option would need to achieve relapse rates 12% lower than those for usual smoking-cessation.
One of the substantial differences between the management of patients with MDR/XDR-TB and patients with other bacterial infections is the very long duration of antibiotic therapy necessary to achieve relapse-free cure.
The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates.
However, T-cell based inT-cell basedcould tinterventionse to augment Mtb-specould immune responses tipachieve relapse-free cure, especially when the effect of antitubalancesis drug toeaugmentdoes not deliver, as in MDR tuberculosimmune XDresponseslosis.
Importantly, treatment did not lead to isoniazid resistance and did not alter the time required to achieve relapse-free TB cure, which together are critical for the design of novel, more efficacious treatment regimens.
Infectious diseases caused by mycobacteria differ from almost all other bacterial infections by the requirement for a very long duration of treatment in order to achieve relapse-free cure with the currently available therapies.
Interestingly, although tofacitinib significantly accelerated the time to apparent lung sterilization when added to Std-Rx in BALB/c mice, it did not alter the time to achieve relapse-free cure, which required five months in both the Std-Rx and 2HRZT/4HRT treatment groups (Table 1).
Interestingly when amikacin and ethionamide were excluded from this combination, the relapse rate did not increase: the group receiving JZM for 6 months also achieved a relapse rate equivalent to that of RHZ after 6 months.
A transversal overcorrection of 30% was achieved for relapse compensation.
The control group receiving the DS TB regimen JRZ achieved a relapse rate equivalent to that of the 6 months standard WHO regimen RHZ after 4 months.
